Sign In
Buy MRNS
$0.550
+0 (+0%)
At Close: May 09, 2025
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results
11:30am, Monday, 04'th May 2020
Marinus Pharmaceuticals, Inc. (MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided an update on its clinical develop
Marinus Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 EPS results.
12:00am, Monday, 04'th May 2020The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:45pm, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pf
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Marinus Pharmaceuticals Announces Formation of Scientific Advisory Board
11:30am, Thursday, 30'th Apr 2020
Marinus Pharmaceuticals, Inc. (MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the formation of a Scientific Ad
Marinus Pharmaceuticals Announces Formation of Scientific Advisory Board
12:00am, Thursday, 30'th Apr 2020Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:01pm, Monday, 27'th Apr 2020
Marinus Pharmaceuticals, Inc. (MRNS) (the “Company” or “Marinus”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today annou
7 Disruptive Biotech Stocks to Buy for 2025
02:56pm, Monday, 27'th Apr 2020
RBC Capital has peered into its crystal ball to reveal some of the market's most exciting biotech stocks. Here are seven that stand out.
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 56'5(c)(4)
12:00am, Monday, 27'th Apr 2020Marinus Pharmaceuticals to Announce First Quarter 2020 Financial Results on Monday, May 4, 2020
11:30am, Thursday, 23'rd Apr 2020
RADNOR, Pa., April 23, 2020 -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare.
Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer to Board of Directors
11:00am, Thursday, 23'rd Apr 2020
Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer to Board of Directors
Benitec Biopharma Appoints Edward Smith to the Board of Directors
01:28am, Wednesday, 15'th Apr 2020
Benitec Biopharma, Inc., a successor entity to Benitec Biopharma Limited (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today announce
MARINUS PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
08:38pm, Monday, 23'rd Mar 2020
Marinus Pharmaceuticals, Inc. (MRNS) (the “Company”, “Marinus”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announc
